Quick Answer
Cinnamon Blood Sugar Meta-Analysis has evidence relevant to safety, limits, and clinician-discussion contexts, but conclusions should stay close to the cited sources. One representative finding is: Conclusions Low certainty evidence suggests that Yanghe decoction may potentially improve the clinical symptoms of diabetic foot, may shorten the wound healing time, and may reduce the wound area.
Key Takeaways
- 01Conclusions Low certainty evidence suggests that Yanghe decoction may potentially improve the clinical symptoms of diabetic foot, may shorten the wound healing time, and may reduce the wound area. [Wang X (2026)]
- 02Purpose To evaluate the potential clinical effect of Yanghe decoction on diabetic foot. [Wang X (2026)]
- 03Methods We comprehensively searched Web of Science, PubMed, The Cochrane Library, Embase, CNKI, Wanfang, and VIP databases from their inception to December 6, 2025, to identify randomized controlled trials (RCTs) investigating Yanghe decoction for DF. [Wang X (2026)]
- 04Diabetes mellitus and prediabetes represent major global health challenges associated with metabolic and cardiovascular complications. [Nampalliwar A (2026)]
The current Migaku evidence database contains 2 reusable source documents for Cinnamon Blood Sugar Meta-Analysis. This answer focuses on safety, limits, and clinician-discussion contexts.
- Conclusions Low certainty evidence suggests that Yanghe decoction may potentially improve the clinical symptoms of diabetic foot, may shorten the wound healing time, and may reduce the wound area. [Wang X (2026); evidence level 1]
- Purpose To evaluate the potential clinical effect of Yanghe decoction on diabetic foot. [Wang X (2026); evidence level 1]
- Methods We comprehensively searched Web of Science, PubMed, The Cochrane Library, Embase, CNKI, Wanfang, and VIP databases from their inception to December 6, 2025, to identify randomized controlled trials (RCTs) investigating Yanghe decoction for DF. [Wang X (2026); evidence level 1]
- Diabetes mellitus and prediabetes represent major global health challenges associated with metabolic and cardiovascular complications. [Nampalliwar A (2026); evidence level 1]
- This review was conducted to evaluate herbal medicines as complementary strategies for glycaemic control and metabolic risk reduction. [Nampalliwar A (2026); evidence level 1]
Evidence levels are sorting aids, not final clinical grades. Level 1 usually indicates systematic-review style evidence, level 2 indicates randomized trials or public-health guidance, and lower levels need more cautious wording.
This page is educational. People with medical conditions, pregnancy, medication use, or unusual symptoms should ask a qualified clinician before changing supplements, medication, or treatment routines.
Sources